In this study, we made a new attempt to deliver IL-10 gene-modified BMDCs into mice with CCl4-induced liver fibrosis to evaluate the immunotherapy effects and explore the molecular mechanisms of DC-IL10 on liver fibrosis. Here, IL10 is linked to Hepatic fibrosis.